华尔街日报：美国盟友争相摆脱对SpaceX(SPCX.O)的依赖。

Conference data published Saturday show Amgen’s Imdelltra combined with AstraZeneca’s Imfinzi cut the risk of death by 58% versus Imfinzi alone in extensive‑stage small‑cell lung cancer. Median overall survival was 21.1 months for the combo versus 12.7 months for Imfinzi monotherapy. Imfinzi is currently the post‑chemotherapy standard for patients without progression after first‑line chemo. Amgen CMO Paul Burton said earlier use of Imdelltra produced greater clinical benefit and called the result unprecedented for advancing treatment in this indication.

For the week to Oct 20, leveraged funds increased net short euro positions by 1,305 contracts to 94.1k contracts, the largest since March 2020, equivalent to roughly €11.8bln of bearish exposure. Market concerns tied to French political turmoil, rising debt pressures and protests weighed on the euro. Investors also cited slowing Euro-area growth and limited ECB hiking scope, which could widen US–Europe rate differentials. EUR/USD fell 0.4% on the week.